TACE与TKI联合或不联合 PD-1 抑制剂治疗晚期肝细胞癌有效性与安全性的Meta分析.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 11, p. 1136, doi. 10.3872/j.issn.1007-385x.2024.11.012
- By:
- Publication type:
- Article
Works by 林雨虹
Results: 5
1
2
基于PD-1/PD-L1 抑制剂联合疗法对比舒尼替尼治疗晚期肾细胞癌安全 性和有效性的Meta分析
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 5, p. 393, doi. 10.3872/j.issn.1007-385x.2023.05.005
- By:
- Publication type:
- Article
3
纳武单抗联合伊匹单抗对比纳武单抗单用方案治疗恶性肿瘤有效性和 安全性的Meta分析
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 464, doi. 10.3872/j.issn.1007-385x.2022.05.011
- By:
- Publication type:
- Article
4
中国福建地区 1474 例地中海贫血基因检测结果分析.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2019, v. 27, n. 3, p. 899, doi. 10.19746/j.cnki.issn1009-2137.2019.03.042
- By:
- Publication type:
- Article
5
PD-1 抑制剂对比化疗或伊匹单抗治疗晚期黑色素瘤安全性和有效性的 Meta分析.
- Published in:
- Chinese Journal of Immunology, 2024, v. 40, n. 1, p. 138, doi. 10.3969/j.issn.1000-484X.2024.01.021
- By:
- Publication type:
- Article